Drug-Eluting Versus Bare-Metal Stents

Abstract

DR. STONE: Welcome to this roundtable discussion. Today, we’ll be focusing on some of the advantages, disadvantages, and nuances of drug-eluting and baremetal stents in the practice of interventional cardiology. My name is Gregg W. Stone; I’m an interventional cardiologist and Professor of Medicine at Columbia University Medical Center and the… (More)

Topics

Cite this paper

@inproceedings{Kirtane2014DrugElutingVB, title={Drug-Eluting Versus Bare-Metal Stents}, author={Ajay J. Kirtane}, year={2014} }